Uniphar

Uniphar FCF per Share

The Free Cash Flow per Share of Uniphar (UPR.IR) as of Oct 11, 2026 is 0.17 EUR. In the previous year, Free Cash Flow per Share was 0.08 EUR — a change of 105.65% (higher).

FCF per Share

0.17EUR

YoY

105.65%

Last updated:

Free Cash Flow per Share of Uniphar is 2025 0.17 EUR. Free Cash Flow per Share of Uniphar was 2024 0.08 EUR. It decreases by 105.65% higher compared to the previous year.

The Uniphar FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-0.07 EUR
Jan 1, 2019
0.37 EUR
Jan 1, 2020
0.18 EUR
Jan 1, 2021
0.14 EUR
Jan 1, 2022
0.25 EUR
Jan 1, 2023
0.08 EUR
Jan 1, 2024
0.08 EUR
Jan 1, 2025
0.17 EUR
The Uniphar FCF per Share history
YEARFCF per ShareYoY
0.17EUR+105.65%
0.08EUR+7.90%
0.08EUR-70.15%
0.25EUR+82.46%
0.14EUR-24.87%
0.18EUR-50.03%
0.37EUR-595.85%
-0.07EUR+203.27%
-0.02EUR-147.68%
0.05EUR—
Access this data via the Eulerpool API

Uniphar Stock analysis

What does Uniphar do? Uniphar PLC is an Irish company that was founded in 1994 and operates in the healthcare industry. The company is headquartered in Dublin and employs over 2,500 people worldwide. The history of Uniphar began as a pharmacy distribution company that supplied medications to retailers and healthcare facilities. Over the years, however, the company has expanded its business model and now offers a wide range of healthcare products and services. Uniphar's business model encompasses three main areas: Healthcare Services, Commercial & Clinical Supply Chain, and Product Access & Specialty Medicines. In the Healthcare Services area, Uniphar provides consulting services, training, and leadership coaching for healthcare facilities. The Commercial & Clinical Supply Chain division includes the storage, logistics, and distribution of medications, as well as the clinical care of patients. The Product Access & Specialty Medicines division focuses on access to medications with high medical demand and rare diseases. Uniphar also offers a wide range of healthcare products, including generics, branded medications, and medical devices. The company has partnerships with leading pharmaceutical companies such as Pfizer, Eli Lilly, and Merck. In recent years, Uniphar has also made several significant acquisitions to expand and diversify its business. In 2018, the company acquired UK-based pharmaceutical distributor Cahill May Roberts, and in 2019, the acquisition of Durbin, an international supplier of clinical supply products, was completed. Uniphar is committed to improving healthcare in Ireland and worldwide and offers a wide range of products and services to achieve this goal. The company has earned a reputation as a reliable partner for healthcare facilities and pharmaceutical companies and is on a steady growth trajectory. Uniphar is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Uniphar stock

Free Cash Flow per Share of Uniphar is 0.17 EUR in 2025.

Free Cash Flow per Share of Uniphar changed from 0.08 EUR to 0.17 EUR, representing a 105.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Uniphar since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

Cash Flow — Uniphar

All Key Metrics — Uniphar